EOLS - Evolus Inc
IEX Last Trade
15.91
0.080 0.503%
Share volume: 475,598
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$15.83
0.08
0.51%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-08 | 2023-03-08 | 2023-05-09 | 2023-08-02 | 2023-11-07 | 2024-03-07 | 2024-05-07 | 2024-07-31 | |
| Assets | |||||||||
| Total Assets | 192.719 M | 177.983 M | 160.235 M | 168.983 M | 167.971 M | 188.998 M | 226.176 M | 233.772 M | |
| Current Assets | 115.946 M | 100.802 M | 84.085 M | 96.460 M | 91.999 M | 112.421 M | 150.265 M | 158.134 M | |
| Inventories | 21.565 M | 18.852 M | 23.418 M | 19.859 M | 17.626 M | 10.998 M | 11.547 M | 13.381 M | |
| Other Current Assets | 7.889 M | 5.580 M | 5.749 M | 5.900 M | 5.224 M | 8.056 M | 7.520 M | 7.933 M | |
| Short Term Investments | 7.889 M | 5.580 M | 5.749 M | 5.900 M | 5.224 M | 8.056 M | 7.520 M | 7.933 M | |
| Total Receivables | 20.920 M | 22.448 M | 23.455 M | 28.996 M | 30.464 M | 30.529 M | 34.240 M | 43.149 M | |
| Current Cash | 65.572 M | 53.922 M | 31.463 M | 41.705 M | 38.685 M | 62.838 M | 96.958 M | 93.671 M | |
| Total Non-current Assets | 76.773 M | 77.181 M | 76.150 M | 72.523 M | 75.972 M | 76.577 M | 75.911 M | 75.638 M | |
| Property Plant Equipment | 1.882 M | 2.616 M | 2.595 M | 2.353 M | 2.130 M | 2.087 M | 2.088 M | 2.284 M | |
| Other Assets | 2.426 M | 2.813 M | 2.682 M | 223.000 K | 222.000 K | 409.000 K | 409.000 K | 409.000 K | |
| Intangible Assets | 49.108 M | 48.597 M | 47.927 M | 47.216 M | 46.505 M | 47.110 M | 46.591 M | 46.275 M | |
| Goodwill | 21.208 M | 21.208 M | 21.208 M | 21.208 M | 21.208 M | 21.208 M | 21.208 M | 21.208 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 192.719 M | 177.983 M | 160.235 M | 168.983 M | 167.971 M | 188.998 M | 226.176 M | 233.772 M | |
| Total liabilities | 163.499 M | 159.484 M | 153.286 M | 175.946 M | 187.339 M | 209.687 M | 207.733 M | 214.458 M | |
| Total current liabilities | 51.271 M | 46.509 M | 40.678 M | 41.349 M | 48.540 M | 48.291 M | 46.801 M | 54.118 M | |
| Accounts Payable | 8.564 M | 8.935 M | 10.185 M | 7.835 M | 11.760 M | 4.271 M | 11.216 M | 10.281 M | |
| Other liabilities | 39.000 M | 39.850 M | 39.600 M | 39.100 M | 38.700 M | 36.200 M | 35.400 M | 34.600 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 71.712 M | 71.879 M | 72.046 M | 94.829 M | 95.094 M | 120.359 M | 120.636 M | 120.918 M | |
| Other liabilities | 39.000 M | 39.850 M | 39.600 M | 39.100 M | 38.700 M | 36.200 M | 35.400 M | 34.600 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 29.220 M | 18.499 M | 6.949 M | -6.963 M | -19.368 M | -20.689 M | 18.443 M | 19.314 M | |
| Common stock | 56.177 M | 56.273 M | 56.476 M | 56.920 M | 57.023 M | 57.256 M | 58.797 M | 62.725 M | |
| Retained earnings | -484.130 M | -497.294 M | -512.085 M | -530.225 M | -547.148 M | -558.979 M | -572.088 M | -583.438 M |